Serology for trachoma surveillance after cessation of mass drug administration.
<h4>Background</h4>Trachoma, caused by Chlamydia trachomatis (Ct), is the leading infectious cause of blindness worldwide. Yearly azithromycin mass drug administration (MDA) plays a central role in efforts to eliminate blinding trachoma as a public health problem. Programmatic decision-m...
Saved in:
| Main Authors: | Diana L Martin, Rhiannon Bid, Frank Sandi, E Brook Goodhew, Patrick A Massae, Augustin Lasway, Heiko Philippin, William Makupa, Sandra Molina, Martin J Holland, David C W Mabey, Chris Drakeley, Patrick J Lammie, Anthony W Solomon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-02-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0003555&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CT694 and pgp3 as serological tools for monitoring trachoma programs.
by: E Brook Goodhew, et al.
Published: (2012-01-01) -
Characterizing trachoma elimination using serology
by: Everlyn Kamau, et al.
Published: (2025-07-01) -
Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells.
by: Victor H Hu, et al.
Published: (2016-05-01) -
Pathogenesis of progressive scarring trachoma in Ethiopia and Tanzania and its implications for disease control: two cohort studies.
by: Matthew J Burton, et al.
Published: (2015-05-01) -
Chlamydia trachomatis ompA variants in trachoma: what do they tell us?
by: Aura A Andreasen, et al.
Published: (2008-09-01)